Nanomedicine in Cancer Immunotherapy
- 1st Edition - January 11, 2024
- Imprint: Academic Press
- Editor: Prashant Kesharwani
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 1 8 7 7 0 - 4
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 1 8 7 7 1 - 1
Nanomedicine in Cancer Immunotherapy bridges the two disciplines of nanotechnology and immunology, summarizing the latest research into novel cancer treatments, often person… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteNanomedicine in Cancer Immunotherapy bridges the two disciplines of nanotechnology and immunology, summarizing the latest research into novel cancer treatments, often personalized to the patient. The book covers a wide range of nanomaterial types for use in cancer immunotherapy, including hydrogel, lipid, exosome, gold and peptide nanoparticles. The preparation, application, pros and cons of each nanomaterial class is reviewed, helping the reader understand the potential for each to tailor their own selections. Nanovaccines are also covered, along with a clinical evaluation and market analysis of nanomedicines for immunotherapy, offering an important clinical and commercial overview of this rapidly developing field.
This book is an interesting reference for those working in the fields of nanotechnology, immunology, and cancer therapeutics, as well as clinicians with an interest in novel nano-based cancer treatments.
This book is an interesting reference for those working in the fields of nanotechnology, immunology, and cancer therapeutics, as well as clinicians with an interest in novel nano-based cancer treatments.
- Provides a single source for a review of the latest research in the development of nanomaterials for cancer immunotherapy
- Introduces the reader to basic principles of immunology and immunotherapy to aid our understanding
- Details a wide range of nanomaterial classes for cancer immunotherapy, with advantages and disadvantages thoroughly analyzed
Researchers and postgraduate students in the fields of materials science, biomedical engineering, pharmaceutical science and nanotechnology, Clinical scientists and R&D groups developing novel materials for biomedical applications
1. Immunoadjuvants for cancer immunotherapy
2. Nanotechnology as an emerging option in cancer immunotherapy
3. Different administration routes for nanovectors in cancer immunotherapy
4. Two-dimensional materialbased nanomedicines for cancer immunotherapy
5. Hydrogel-based nanomedicines for cancer immunotherapy
6. Exosomes-based nanomedicines for cancer immunotherapy
7. Lipid-based nanomedicines for cancer immunotherapy
8. Inorganic nanoparticle-based nanomedicines for cancer immunotherapy
9. Liposome-based nanomedicines for cancer immunotherapy
10. Biomembrane-based nanoparticles for cancer immunotherapy
11. Dendrimer-based nanomedicines for cancer immunotherapy
12. Magnetic nanocarriers for cancer immunotherapy
13. Inhaled delivery of immunotherapy for treatment of lung cancer
14. Nano-based vaccination and their administration routes in cancer immunotherapy
15. Current status, challenges, and future perspective of nanomedicine-based cancer immunotherapy
2. Nanotechnology as an emerging option in cancer immunotherapy
3. Different administration routes for nanovectors in cancer immunotherapy
4. Two-dimensional materialbased nanomedicines for cancer immunotherapy
5. Hydrogel-based nanomedicines for cancer immunotherapy
6. Exosomes-based nanomedicines for cancer immunotherapy
7. Lipid-based nanomedicines for cancer immunotherapy
8. Inorganic nanoparticle-based nanomedicines for cancer immunotherapy
9. Liposome-based nanomedicines for cancer immunotherapy
10. Biomembrane-based nanoparticles for cancer immunotherapy
11. Dendrimer-based nanomedicines for cancer immunotherapy
12. Magnetic nanocarriers for cancer immunotherapy
13. Inhaled delivery of immunotherapy for treatment of lung cancer
14. Nano-based vaccination and their administration routes in cancer immunotherapy
15. Current status, challenges, and future perspective of nanomedicine-based cancer immunotherapy
- Edition: 1
- Published: January 11, 2024
- No. of pages (Paperback): 500
- Imprint: Academic Press
- Language: English
- Paperback ISBN: 9780443187704
- eBook ISBN: 9780443187711
PK
Prashant Kesharwani
Dr. Prashant Kesharwani is assistant professor of Pharmaceutics at Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya, Sagar, Madhya Pradesh, India. He has more than 12 years of teaching, research, and industrial experience at international levels from various countries, including the United States, Malaysia, and India. An overarching goal of his current research is the development of nanoengineered drug delivery systems for various diseases. He has more than 350 international publications in well-reputed journals and more than 25 international books (Elsevier). He is a recipient of many research grants from various funding bodies. He is also the recipient of several internationally acclaimed awards, such as “USERN Laureate award”, most prestigious “SERB-Ramanujan Fellowship Award”. He actively participates in outreach and scientific dissemination for the service of the wider community. His Number of citations is = 26779; h-index = 85; i-10 index = 370 (According to google scholar on March 2025). He has more than 30 international publications published in very high impact factor journals (Progress in Polymer Sciences IF 32.063, Molecular Sciences IF 41.444, Progress in Material Sciences IF 48.580, Advanced Materials IF 29.4, Drug Resistance Update IF 22.841 and Material Todays IF 32.072). He has presented many invited talks and oral presentations at prestigious scientific peer-conferences, received international acclaims and awards for research contribution, supervised students/junior researchers and actively participated in outreach and scientific dissemination for the service of the wider community.
Affiliations and expertise
Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya, Sagar, Madhya Pradesh, IndiaRead Nanomedicine in Cancer Immunotherapy on ScienceDirect